Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement
SAN DIEGO--(BUSINESS WIRE)--$REVB #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today announced an exclusive worldwide license agreement w...
Source: pharmiweb.com